Clinical Trials & Drug Development SpecialistsPage 5

Alexander Edward Drilon, MD

Chief, Early Drug Development Service; Associate Attending Physician, Thoracic Oncology Service

Oncology

Shanu Modi, MD

Breast Medical Oncologist

Oncology

Svetomir Markovic, M.D.

Professor, Internal Medicine, Mayo Clinic Alix School of Medicine

Oncology

Debasish Tripathy, M.D.

Professor of Medicine; Chair, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center

Hematology

Maha Hussain, MB,CHB

Genevieve E. Teuton Professor of Medicine; Professor, Medicine (Hematology and Oncology); Deputy Director, Robert H. Lurie Comprehensive Cancer Center

Oncology

Jason Mouabbi, M.D.

Assistant Professor, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Oncology

Bruce Smith, M.D.

Oncology

Ramaswamy Govindan, MD

Anheuser Busch Endowed Chair in Medical Oncology; Associate Chief of Oncology, Washington University

Oncology

Pasi Antero Janne, MD PHD

Senior Vice President for Translational Medicine; Scientific Director, Belfer Center for Applied Cancer Science; Professor of Medicine, Harvard Medical School

Oncology

Arlene Siefker-Radtke, M.D.

Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Oncology

Ali Moussa, M.D.

Hematology

Michael Atkins, M.D.

Oncology

David Relman, M.D.

Professor and Professor of Microbiology and Immunology

Infectious Disease

Brian Badgwell, M.D.

Professor of Surgery, Hamill Foundation Distinguished Professorship in Honor of Dr. Richard G. Martin, Sr, Division of Surgery, The University of Texas MD Anderson Cancer Center

Oncology

Gary Ulaner, M.D. PH.D.

James & Pamela Muzzy Endowed Chair of Molecular Imaging and Therapy (MIT); Director, Molecular Imaging and Therapy; Professor of Radiology and Translational Genomics, University of Southern California

Oncology

Jeffrey Clark, MD

Associate Professor, Medicine, Harvard Medical School

Oncology

Lecia Sequist, MD

Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center

Oncology

Alicia Morgans, MD

Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program

Oncology

Frank Hodi, MD

Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center

Oncology

Kate Lathrop, M.D.

Associate Professor/Clinical; Program Director, Medical Oncology and Hematology Fellowship Program; Assistant Dean of Undergraduate Research, Long School of Medicine

Oncology